158 related articles for article (PubMed ID: 34885014)
21. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
[TBL] [Abstract][Full Text] [Related]
22. Drug-induced acute pancreatitis due to medications used for inflammatory bowel disease: A VigiBase pharmacovigilance database study.
Lee AA; Gupta S; Labban M; Cao FT; Trinh QD; McNabb-Baltar J
Pancreatology; 2023 Sep; 23(6):569-573. PubMed ID: 37302896
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
[TBL] [Abstract][Full Text] [Related]
24. Drug-induced thrombotic microangiopathy using the Japanese pharmacovigilance database.
Niinomi I; Hosohata K; Oyama S; Inada A; Hirai T; Iwanaga K
Int J Clin Pharmacol Ther; 2020 Oct; 58(10):543-549. PubMed ID: 32631486
[TBL] [Abstract][Full Text] [Related]
25. Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study.
Rey A; Batteux B; Laville SM; Marienne J; Masmoudi K; Gras-Champel V; Liabeuf S
Arthritis Res Ther; 2019 Nov; 21(1):229. PubMed ID: 31703711
[TBL] [Abstract][Full Text] [Related]
26. Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase.
Perino J; Mottal N; Bohbot Y; Servant V; Berroneau A; Poustis P; Fenaux P; Laribi K; Charbonnier A; Bilion E; Calmettes C; Bégaud B; Pigneux A; Milpied N; Miremont-Salamé G; Théophile H; Dimicoli-Salazar S
Br J Clin Pharmacol; 2020 May; 86(5):991-998. PubMed ID: 31912911
[TBL] [Abstract][Full Text] [Related]
27. First-line therapeutic strategy for patients with advanced non-small cell lung cancer with Leu858Arg epidermal growth factor receptor mutations: a Bayesian network meta-analysis.
Chen C; Zhang C; Lin H; Liu Q; Wu L; Zhou C; Zhang J
Ther Adv Chronic Dis; 2022; 13():20406223221125706. PubMed ID: 36274751
[TBL] [Abstract][Full Text] [Related]
28. Thromboembolic Events Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System (FAERS) Database.
Yang X; Yang B; Li D; Pan W; Tong Q; Wang L; Chen D; Fu C
Clin Drug Investig; 2024 Mar; 44(3):199-207. PubMed ID: 38376794
[TBL] [Abstract][Full Text] [Related]
29. Safety of Monoclonal Antibodies Inhibiting PCSK9 in Pregnancy: Disproportionality Analysis in VigiBase®.
Noseda R; Bedussi F; Panchaud A; Ceschi A
Clin Pharmacol Ther; 2024 Apr; ():. PubMed ID: 38637956
[TBL] [Abstract][Full Text] [Related]
30. Drug-induced tics: An observational postmarketing study.
Touafchia D; Montastruc F; Lapeyre-Mestre M; Rousseau V; Chebane L; Revet A
Hum Psychopharmacol; 2020 Jul; 35(4):e2734. PubMed ID: 32352603
[TBL] [Abstract][Full Text] [Related]
31. Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase.
Vallejo-Yagüe E; Weiler S; Micheroli R; Burden AM
Drug Saf; 2020 Sep; 43(9):881-891. PubMed ID: 32533433
[TBL] [Abstract][Full Text] [Related]
32. Tramadol-induced hiccups: a case-noncase study in the European pharmacovigilance database.
García M; Lertxundi U; Aguirre C
Ther Adv Drug Saf; 2021; 12():20420986211021230. PubMed ID: 34211690
[TBL] [Abstract][Full Text] [Related]
33. Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.
Sagwa EL; Souverein PC; Ribeiro I; Leufkens HG; Mantel-Teeuwisse AK
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):1-8. PubMed ID: 27868278
[TBL] [Abstract][Full Text] [Related]
34. Diarrhoea with the angiotensin receptor neprilysin inhibitor sacubitril + valsartan: A pharmacovigilance study.
Guion-Firmin J; Tessier S; Lepelley M; Faillie JL; Montastruc JL
Fundam Clin Pharmacol; 2022 Apr; 36(2):378-389. PubMed ID: 34260768
[TBL] [Abstract][Full Text] [Related]
35. Oral phosphodiesterase type 5 inhibitors and priapism: A VigiBase analysis.
Abbasi B; Shaw NM; Lui JL; Hakam N; Nabavizadeh B; Breyer BN
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5721. PubMed ID: 37909414
[TBL] [Abstract][Full Text] [Related]
36. Renal toxicities in immune checkpoint inhibitors with or without chemotherapy: An observational, retrospective, pharmacovigilance study leveraging US FARES database.
Hu F; Zhai Y; Yuan L; Liang J; Xu J; Guo X; Zhou X; Lin Z; Sun J; Ye X; He J
Cancer Med; 2021 Dec; 10(24):8754-8762. PubMed ID: 34845857
[TBL] [Abstract][Full Text] [Related]
37. Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®.
Noseda R; Bedussi F; Gobbi C; Ceschi A; Zecca C
Cephalalgia; 2023 Apr; 43(4):3331024231158083. PubMed ID: 36855950
[TBL] [Abstract][Full Text] [Related]
38. Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system.
Kumar V; Singh AP; Wheeler N; Galindo CL; Kim JJ
Expert Opin Drug Saf; 2021 Nov; 20(11):1443-1450. PubMed ID: 34259127
[TBL] [Abstract][Full Text] [Related]
39. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
[TBL] [Abstract][Full Text] [Related]
40. Reporting of Acute Inflammatory Neuropathies with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase.
Noseda R; Ripellino P; Ghidossi S; Bertoli R; Ceschi A
Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
